Google
Trusted Resources: News & Events
Latest announcements and gatherings
Capitol Hill Briefing Held to Encourage Sickle Cell Research and Treatment
Earlier today, a briefing was hosted on Capitol Hill to highlight advancements in sickle cell disease (SCD) research and treatment options.
The briefing was hosted by the American Society for Blood and Marrow Transplantation (ASBMT), American Society of Hematology (ASH), American Society for Gene & Cell Therapy, National Marrow Donor Program/Be the Match, Sickle Cell Disease Association of America, Inc. and Pediatric Hospital Sickle Cell Collaborative, in partnership with The House Research & Development Caucus, the Congressional Caucus to Cure Blood Cancers and Other Blood Disorders and the Congressional Sickle Cell Disease Caucus. Three prominent members of congress – Doris Matsui (CA-6), Bill Foster, PhD (IL-11) and Danny Davis (IL-7) – also participated.
+myBinderRelated Content
-
ADDMEDICA receives FDA-approval for orphan drug Siklos®, first and sole hydroxyurea-based treatment for paediatric ...ADDMEDICA has announced that the...
-
Calimmune Expands Lentiviral Gene Therapy Pipeline Through License of Sickle Cell Disease Therapeutic CandidateLicense of Gamma-Globin from Cincinnati ...
-
SCANJ: 11th Annual Statewide Sickle Cell Disease SymposiumWe enthusiastically invite you to The S...
-
FDA Clears Graphite Bio to Begin Trial for Gene Therapy in Sickle Cell DiseaseIn response to Graphite Bio’s investig...
-
Severe loss of circulating dendritic cell subsets in splenectomised children with sickle cell diseaseSplenectomy is the mainstay of long-term...
-
Vaccinations after hematopoietic cell transplantHematopoietic cell transplant recipients...
-
Debbie’s Story on BBC2 Hospitalhttps://www.facebook.com/bbctwo/videos/1...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.